In an event held at 8:45 a.m. ET on June 30 by the American Enterprise Institute (AEI), some leading experts of the States discuss the “Science Policy After the COVID-19 Crisis”.
Panel I:
Jonathan Fuller, Visiting Scholar, Department of Bioethics, National Institutes of Health; Marc Lipsitch, Professor of Epidemiology, T. H. Chan School of Public Health, Harvard University; and Emily Ricotta, Independent Research Scholar in the Division of Intramural Research, National Institute on Allergies and Infectious Diseases, will discuss “Evidence and Policy After COVID-19”.
M. Anthony Mills, Senior Fellow, AEI moderates the discussion of panel I.
Panel II:
Mark McClellan, Director of the Duke-Margolis Center for Health Policy, Duke University, and Janet Woodcock, Principal Deputy Commissioner, Food and Drug Administration, will discuss “COVID-19’s Lessons for Institutional Reform”.
M. Anthony Mills, Senior Fellow, AEI moderates the discussion of panel II.
NTD